Literature DB >> 9792704

The mechanism underlying cystic fibrosis transmembrane conductance regulator transport from the endoplasmic reticulum to the proteasome includes Sec61beta and a cytosolic, deglycosylated intermediary.

Z Bebök1, C Mazzochi, S A King, J S Hong, E J Sorscher.   

Abstract

Endoplasmic reticulum (ER) degradation pathways can selectively route proteins away from folding and maturation. Both soluble and integral membrane proteins can be targeted from the ER to proteasomal degradation in this fashion. The cystic fibrosis transmembrane conductance regulator (CFTR) is an integral, multidomain membrane protein localized to the apical surface of epithelial cells that functions to facilitate Cl- transport. CFTR was among the first membrane proteins for which a role of the proteasome in ER-related degradation was described. However, the signals that route CFTR to ubiquitination and subsequent degradation are not known. Moreover, limited information is available concerning the subcellular localization of polyubiquitinated CFTR or mechanisms underlying retrograde dislocation of CFTR from the ER membrane to the proteasome either before or after ubiquitination. In the present study, we show that proteasome inhibition with clasto-lactacystin beta-lactone (4 microM, 1 h) stabilizes the presence of a deglycosylated CFTR intermediate for up to 5 h without increasing the core glycosylated (band B) form of CFTR. Deglycosylated CFTR is present under the same conditions that result in accumulation of polyubiquitinated CFTR. Moreover, the deglycosylated form of both wild type and DeltaF508 CFTR can be found in the cytosolic fraction. Both the level and stability of cytosolic, deglycosylated CFTR are increased by proteasome blockade. During retrograde translocation from the ER to the cytosol, CFTR associates with the Sec61 trimeric complex. Sec61 is the key component of the mammalian co-translational protein translocation system and has been proposed to function as a two way channel that transports proteins both into the ER and back to the cytosol for degradation. We show that the level of the Sec61.CFTR complexes are highest when CFTR degradation proceeds at the greatest rate (approximately 90 min after pulse labeling). Quantities of Sec61.CFTR complexes are also increased by inhibition of the proteasome. Based on these results, we propose a model in which complex membrane proteins such as CFTR are transported through the Sec61 trimeric complex back to the cytosol, escorted by the beta subunit of Sec61, and degraded by the proteasome or by other proteolytic systems.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792704     DOI: 10.1074/jbc.273.45.29873

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  The cytosolic tail of class I MHC heavy chain is required for its dislocation by the human cytomegalovirus US2 and US11 gene products.

Authors:  C M Story; M H Furman; H L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

2.  Visualization of the ER-to-cytosol dislocation reaction of a type I membrane protein.

Authors:  Edda Fiebiger; Craig Story; Hidde L Ploegh; Domenico Tortorella
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

3.  A novel quality control compartment derived from the endoplasmic reticulum.

Authors:  S Kamhi-Nesher; M Shenkman; S Tolchinsky; S V Fromm; R Ehrlich; G Z Lederkremer
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

4.  Hsp70 molecular chaperone facilitates endoplasmic reticulum-associated protein degradation of cystic fibrosis transmembrane conductance regulator in yeast.

Authors:  Y Zhang; G Nijbroek; M L Sullivan; A A McCracken; S C Watkins; S Michaelis; J L Brodsky
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

5.  VCP/p97 AAA-ATPase does not interact with the endogenous wild-type cystic fibrosis transmembrane conductance regulator.

Authors:  Rebecca F Goldstein; Ashutosh Niraj; Todd P Sanderson; Landon S Wilson; Andras Rab; Helen Kim; Zsuzsa Bebok; James F Collawn
Journal:  Am J Respir Cell Mol Biol       Date:  2007-02-01       Impact factor: 6.914

6.  A synonymous single nucleotide polymorphism in DeltaF508 CFTR alters the secondary structure of the mRNA and the expression of the mutant protein.

Authors:  Rafal A Bartoszewski; Michael Jablonsky; Sylwia Bartoszewska; Lauren Stevenson; Qun Dai; John Kappes; James F Collawn; Zsuzsa Bebok
Journal:  J Biol Chem       Date:  2010-07-13       Impact factor: 5.157

Review 7.  Terminal glycosylation in cystic fibrosis (CF): a review emphasizing the airway epithelial cell.

Authors:  A D Rhim; L Stoykova; M C Glick; T F Scanlin
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

Review 8.  The cytoplasmic peptide:N-glycanase (NGLY1) - Structure, expression and cellular functions.

Authors:  Tadashi Suzuki; Chengcheng Huang; Haruhiko Fujihira
Journal:  Gene       Date:  2015-11-30       Impact factor: 3.688

9.  A synonymous codon change alters the drug sensitivity of ΔF508 cystic fibrosis transmembrane conductance regulator.

Authors:  Vedrana Bali; Ahmed Lazrak; Purushotham Guroji; Lianwu Fu; Sadis Matalon; Zsuzsanna Bebok
Journal:  FASEB J       Date:  2015-09-03       Impact factor: 5.191

10.  Luteinizing hormone receptor ectodomain splice variant misroutes the full-length receptor into a subcompartment of the endoplasmic reticulum.

Authors:  Pirjo M Apaja; Jussi T Tuusa; E Maritta Pietilä; Hannu J Rajaniemi; Ulla E Petäjä-Repo
Journal:  Mol Biol Cell       Date:  2006-02-22       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.